170 related articles for article (PubMed ID: 28912071)
1. Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study.
Martelli G; Miceli R; Folli S; Guzzetti E; Chifu C; Maugeri I; Ferranti C; Bianchi G; Capri G; Carcangiu ML; Paolini B; Agresti R; Ferraris C; Piromalli D; Greco M
Eur J Surg Oncol; 2017 Nov; 43(11):2012-2020. PubMed ID: 28912071
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.
Nogi H; Uchida K; Mimoto R; Kamio M; Shioya H; Toriumi Y; Suzuki M; Nagasaki E; Kobayashi T; Takeyama H
Clin Breast Cancer; 2017 Dec; 17(8):644-649. PubMed ID: 28601382
[TBL] [Abstract][Full Text] [Related]
3. Sentinel Node Biopsy Alone or With Axillary Dissection in Breast Cancer Patients After Primary Chemotherapy: Long-Term Results of a Prospective Interventional Study.
Martelli G; Barretta F; Miceli R; Folli S; Maugeri I; Listorti C; Scaperrotta G; Baili P; Pruneri G; Capri G; Ferraris C
Ann Surg; 2022 Nov; 276(5):e544-e552. PubMed ID: 33065651
[TBL] [Abstract][Full Text] [Related]
4. Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up.
Kahler-Ribeiro-Fontana S; Pagan E; Magnoni F; Vicini E; Morigi C; Corso G; Intra M; Canegallo F; Ratini S; Leonardi MC; La Rocca E; Bagnardi V; Montagna E; Colleoni M; Viale G; Bottiglieri L; Grana CM; Biasuz JV; Veronesi P; Galimberti V
Eur J Surg Oncol; 2021 Apr; 47(4):804-812. PubMed ID: 33092968
[TBL] [Abstract][Full Text] [Related]
5. Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment.
Galimberti V; Ribeiro Fontana SK; Maisonneuve P; Steccanella F; Vento AR; Intra M; Naninato P; Caldarella P; Iorfida M; Colleoni M; Viale G; Grana CM; Rotmensz N; Luini A
Eur J Surg Oncol; 2016 Mar; 42(3):361-8. PubMed ID: 26746091
[TBL] [Abstract][Full Text] [Related]
6. Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node.
Soni NK; Spillane AJ
ANZ J Surg; 2005 May; 75(5):292-9. PubMed ID: 15932439
[TBL] [Abstract][Full Text] [Related]
7. Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment.
van der Heiden-van der Loo M; de Munck L; Sonke GS; van Dalen T; van Diest PJ; van den Bongard HJ; Peeters PH; Rutgers EJ
Eur J Cancer; 2015 May; 51(8):915-21. PubMed ID: 25857549
[TBL] [Abstract][Full Text] [Related]
8. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important.
Jones JL; Zabicki K; Christian RL; Gadd MA; Hughes KS; Lesnikoski BA; Rhei E; Specht MC; Dominguez FJ; Smith BL
Am J Surg; 2005 Oct; 190(4):517-20. PubMed ID: 16164912
[TBL] [Abstract][Full Text] [Related]
9. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
10. Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies.
Vriens BEPJ; Keymeulen KBMI; Kroep JR; Charehbili A; Peer PG; de Boer M; Aarts MJB; Heuts EM; Tjan-Heijnen VCG;
Oncotarget; 2017 Jul; 8(28):46557-46564. PubMed ID: 28177921
[TBL] [Abstract][Full Text] [Related]
11. Safety of sentinel node biopsy in breast cancer patients who receive a second radioisotope injection after visualization failure in lymphoscintigraphy.
Meretoja TJ; Joensuu H; Heikkilä PS; Leidenius MH
J Surg Oncol; 2010 Nov; 102(6):649-55. PubMed ID: 20976732
[TBL] [Abstract][Full Text] [Related]
12. [Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer. Its relation with molecular subtypes].
Ruano R; Ramos M; García-Talavera JR; Ramos T; Rosero AS; González-Orus JM; Sancho M
Rev Esp Med Nucl Imagen Mol; 2014; 33(6):340-5. PubMed ID: 24856234
[TBL] [Abstract][Full Text] [Related]
13. [Sentinel node biopsy for breast cancer patients at the Bács-Kiskun County Teaching Hospital].
Cserni G; Rajtár M; Boross G; Sinkó M; Svébis M; Baltás B; Ambrózay E; Szúcs M
Orv Hetil; 2002 Mar; 143(9):437-46. PubMed ID: 12013684
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study.
Veronesi U; Viale G; Paganelli G; Zurrida S; Luini A; Galimberti V; Veronesi P; Intra M; Maisonneuve P; Zucca F; Gatti G; Mazzarol G; De Cicco C; Vezzoli D
Ann Surg; 2010 Apr; 251(4):595-600. PubMed ID: 20195151
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single-center retrospective analysis with long follow-up.
Ogawa Y; Ikeda K; Watanabe C; Kamei Y; Tokunaga S; Tsuboguchi Y; Inoue T; Fukushima H; Ichiki M
Surg Today; 2018 Jan; 48(1):87-94. PubMed ID: 28647776
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer.
Koslow SB; Eisenberg RE; Qiu Q; Chen Z; Swistel A; Shin SJ
Am Surg; 2014 Feb; 80(2):171-7. PubMed ID: 24480218
[TBL] [Abstract][Full Text] [Related]
17. Neo-adjuvant chemotherapy and axillary de-escalation management for patients with clinically node-negative breast cancer.
Shi ZQ; Qiu PF; Liu YB; Cong BB; Zhao T; Chen P; Wang CJ; Zhang ZP; Sun X; Wang YS
Breast J; 2019 Nov; 25(6):1154-1159. PubMed ID: 31332886
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
[TBL] [Abstract][Full Text] [Related]
19. Is my patient an appropriate candidate for sentinel node biopsy? Less axillary surgery, for the right patients. Critical review and grades of recommendation.
Bessa JF; Novita GG; Testa L; Freitas-Junior R; Marta GN
Surg Oncol; 2024 Jun; 54():102064. PubMed ID: 38518660
[TBL] [Abstract][Full Text] [Related]
20. Accurate axillary nodal staging can be achieved after neoadjuvant therapy for locally advanced breast cancer.
Patel NA; Piper G; Patel JA; Malay MB; Julian TB
Am Surg; 2004 Aug; 70(8):696-9; discussion 699-700. PubMed ID: 15328803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
